We observed that the expression of BTK also induced the upregulation of MDM2 protein levels in normal and cancer cells with wild type p53, even in the absence of damage (Figure 1B and Supplementary Figure 1A), consistent with the critical role of BTK in the activation of p53 target genes [36]. The gene discussed is TP53; the disease is cancer.